Page 2 of 318 : Previous Page : Next Page
Posts
- Category: 2010 (continued)
- FDA Mulling End to Avandia-Actos Trial on Safety Worries
- FDA Roundup: Menthol Cigarettes, CT Scans, No Go on Jet-Lag Drug
- FDA Shoots Down New Combo Heart Drug
- FDA to Review Bone Drugs After Studies Report Hip Breaks
- Feds Want Documents on Boston Scientific’s Defibrillator Recall
- Financial Aid for Cancer Patients Strained After ‘Deluge’ of Requests
- Fred Hassan Finds New Perch
- Generic Business Faces Tougher Slog
- Genzyme Faces FDA Enforcement Moves Over Production Problems
- Genzyme Faces FDA Enforcement Moves Over Production Problems
- Genzyme Seats Activist (Whitworth) to Thwart Another One (Icahn)
- Harvard Docs to Insurance Companies: Drop the Big Macs
- Health Bill: From Reconciliation to ‘Deeming’
- Health-Care Bill: Going Back for Another Vote
- Health-Care Bill: When Might the White House Celebration Begin?
- Health-Care Overhaul and Drugmaker Outlook: Amgen
- Health-Care Overhaul and Industry Outlook: Baxter
- Health-Care Overhaul and Pharma Outlook: A Scorecard
- Heart Roundup: Device-Maker Probes, Too Many Angiograms
- How Medical Staffs Can Learn From the Mistakes of Others
- In Massachusetts, the Pros and Cons of New Imaging Technology
- In the Hot Seat, WellPoint Plans to Review Rate Increases
- InterMune Stock Gets Boost as FDA Staff Questions Lung Drug
- InterMune’s Lung Drug Gets Backing From FDA Panel
- Is Fetal Pain the Newest Abortion Battleground?
- Is the Tanning Tax Half Baked?
- Is There a Competent Doctor in the House?
- Is Varmus Headed to the National Cancer Institute?
- Just Between Us Girls, iVillage Launches Health Site for Women
- Latest U.S. Swine-Flu Problem: Getting Rid of the Unused Vaccine
- Leader in Heart Medicine Dies at 85
- Let the Sun Shine In: Payments to Docs from Companies to be Disclosed
- London Calling: Pfizer’s Mackay to Head R&D at AstraZeneca
- Lots of Prostate Cancer Radiation Options, Little Clue What Works
- Lowden’s Medical Barter Idea: Not So Nuts After All?
- Massachusetts Hospital Chain to Go For-Profit
- Maternal Mortality: Global Death Rate Drops, or Does It?
- Medicaid Discounts Hit Lilly; What About Other Companies?
- Medical Groups Sign on to Tough Ethics Rules
- Medicare Docs Guess at Paychecks Amid Reimbursement Questions
- Medicare Pay Cuts Averted, Cobra Extended — Why All the Sad Faces?
- Menu Labeling to Go National, Thanks to Health Bill’s Passage
- Merck and Portola: Finding a Blood Thinner’s Sweet Spot
- Merck, Sanofi Herd Animal-Health Businesses Into One Corral
- Mercury Levels in Tuna Sushi Vary; Is Jeremy Piven Vindicated?
- New Rules on Medicaid Discounts a Bummer for States
- Nissen Picks Out the Wrong Red Dress in Criticism of Industry Ties
- Not ‘War and Peace’ But Orphan-Drug Applications Are Few
- Nursing Homes Chafe Under Drug-Prescribing Rules
- Obama Says Hospitals Must Allow Visitation Rights
Leave a Reply